ABSTRACT
The fitness of multidrug-resistant tuberculosis (MDR-TB) is thought to be an important determinant of a strain’s ability to be transmitted. Studies in the laboratory have demonstrated that MDR-TB strains have reduced fitness but the relative transmissibility of MDR-TB versus drug-susceptible (DS) TB strains in human populations remains unresolved. We used data on genomic clustering from our previous molecular epidemiological study in Songjiang (2011-2020) and Wusheng (2009-2020), China, to compare the relative transmissibility of MDR-TB versus DS-TB. Genomic clusters were defined with a threshold distance of 12-single-nucleotide-polymorphisms and the risk for MDR-TB clustering was analyzed by logistic regression. In total, 2212 culture-positive pulmonary TB patients were enrolled in Songjiang and 1289 in Wusheng. The clustering rates of MDR-TB and DS-TB strains were 19.4% (20/103) and 26.3% (509/1936), respectively in Songjiang, and 43.9% (29/66) and 26.0% (293/1128) in Wusheng. The risk of MDR-TB clustering was 2.34 (95% CI 1.38-3.94) times higher than DS-TB clustering in Wusheng and 0.64 (95% CI 0.38-1.06) times lower in Songjiang. Neither lineage 2, compensatory mutations nor rpoB S450L were significantly associated with MDR-TB transmission, and katG S315 T increased MDR-TB transmission only in Wusheng (OR 5.28, 95% CI 1.42-19.21). MDR-TB was not more transmissible than DS-TB in either Songjiang or Wusheng. It appears that the different transmissibility of MDR-TB in Songjiang and Wusheng is likely due to differences in the quality of the local TB control programmes. Suggesting that the most effective way to control MDR-TB is by improving local TB control programmes.
Acknowledgments
We thank the tuberculosis public health teams in the Songjiang District Centre for Disease Control and Prevention and the Wusheng County Centre for Disease Control and Prevention. We also thank Prof. Sebastien Gagneux for his valuable comments on this manuscript.
Authors’ contributions
M.L., Q.J., L.X., C.Y., X.S., C.C., and Q.G. conceived, designed and managed the study. L.L., M.G., Y.J., S.Z., Y.Q., J.H., and X.G. contributed the demographic, clinical and microbiological data. M.L., Q.J., and Y.C. did the data analyses. M.L., Q.J., C.Y., Y.C., H.T., and Q.G. drafted and revised the manuscript. All authors contributed to and gave input to the final article.
Data availability
The datasets used and analyzed during the current study are not accessible online, but may be made available upon written request to the corresponding author. Sequencing data were deposited in the Genome Sequence Archive (https://bigd.big.ac.cn/gsa) under BioProject PRJCA008815 and PRJCA010372.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Ethical approval
The study was approved by the institutional review board of Biomedical Sciences, Fudan University and all enrolled patients provided written informed consent.